2003 Kern Aspen Lipid Conference: Integrative Mechanisms

2003 年 Kern Aspen 脂质会议:综合机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application is to seek funding for the 2003 Kern Aspen Lipid Conference, to be held in Aspen, CO, on August 16-19, 2003. The title of the conference is "Integrative Mechanisms of Lipid Metabolism". The goal of this meeting will be to provide attendees the opportunity to learn about the state-of-the-art findings across broad areas of lipid metabolism that extend beyond any one single research area. Cross fertilization of lipid research with ideas from a variety of approaches should be educational to all, and may promote new research initiatives. Accordingly, three co chairs for this year's meeting were selected, all of whom have different backgrounds. Dr. Lawrence Rudel is a member of the board of directors and is an expert in lipoprotein metabolism and cholesterol transport. Dr. Robert Farese, Jr. is an expert in triacylglycerol and fatty acid metabolism and has developed numerous animal models of acylglyceride metabolism. Dr. Joachim Herz is an expert in studies of the central nervous system, where he has pioneered identification and functional evaluation of several cell surface receptors that are required for normal brain development and function. A fourth session will cover transcription factors and genetics associated with the metabolic syndrome, and this session will be led by Dr. Christopher Glass. The conference is organized to bring together investigators in divergent fields in lipid research with the goal to foster further insights into the pathogenesis of diseases involving lipid metabolism including atherosclerosis, diabetes, and obesity. Although some of the proposed subjects may be covered at other specialized meetings, we are unaware of a single conference, which includes the diversity of the various fields assembled to exchange new advances in lipid metabolism across such a wide ranging arena. The timeliness of this meeting is viewed as a strength.
描述(由申请人提供): 本申请旨在为将于 2003 年 8 月 16 日至 19 日在科罗拉多州阿斯彭举行的 2003 年克恩阿斯彭脂质会议寻求资金。会议的标题是“脂质代谢的综合机制”。本次会议的目标是为与会者提供了解脂质代谢广泛领域最新研究成果的机会,这些研究成果超出了任何一个单一的研究领域。脂质研究与多种方法的思想的交叉融合应该对所有人都有教育意义,并可能促进新的研究举措。据此,今年会议选出了三名共同主席,他们都有不同的背景。 Lawrence Rudel 博士是董事会成员,是脂蛋白代谢和胆固醇转运方面的专家。 Robert Farese, Jr. 博士是三酰甘油和脂肪酸代谢方面的专家,开发了多种酰基甘油代谢动物模型。 Joachim Herz 博士是中枢神经系统研究专家,他率先对正常大脑发育和功能所需的几种细胞表面受体进行了识别和功能评估。第四场会议将涵盖与代谢综合征相关的转录因子和遗传学,本场会议将由 Christopher Glass 博士主持。该会议的组织目的是将脂质研究不同领域的研究人员聚集在一起,目的是进一步了解涉及脂质代谢的疾病的发病机制,包括动脉粥样硬化、糖尿病和肥胖。尽管一些拟议的主题可能会在其他专门会议上涵盖,但我们不知道有一个会议,其中包括各个领域的多样性,聚集在一起,在如此广泛的领域交流脂质代谢的新进展。这次会议的及时性被视为一个优势。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lawrence L Rudel其他文献

Study of PRD125, a SOAT2-Selective Inhibitor, in Atherogenic Mouse Model.
PRD125(一种 SOAT2 选择性抑制剂)在致动脉粥样硬化小鼠模型中的研究。
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ohshiro T,Sawyer J;Matthew A Davis;Ohtawa M;Nagamitsu T;Lawrence L Rudel;Tomoda H.
  • 通讯作者:
    Tomoda H.

Lawrence L Rudel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lawrence L Rudel', 18)}}的其他基金

Administrative and Biostatistics Core
行政和生物统计核心
  • 批准号:
    7537466
  • 财政年份:
    2008
  • 资助金额:
    $ 1.7万
  • 项目类别:
ACAT2-Derived LDL Cholesteryl Esters In Atherosclerosis
ACAT2 衍生的 LDL 胆固醇酯在动脉粥样硬化中的作用
  • 批准号:
    7537452
  • 财政年份:
    2008
  • 资助金额:
    $ 1.7万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7114215
  • 财政年份:
    2006
  • 资助金额:
    $ 1.7万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7577578
  • 财政年份:
    2006
  • 资助金额:
    $ 1.7万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7184324
  • 财政年份:
    2006
  • 资助金额:
    $ 1.7万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7768434
  • 财政年份:
    2006
  • 资助金额:
    $ 1.7万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7369693
  • 财政年份:
    2006
  • 资助金额:
    $ 1.7万
  • 项目类别:
Project 1- Mechanisms of Atherosclerosis Prevention
项目1-动脉粥样硬化预防机制
  • 批准号:
    6946076
  • 财政年份:
    2005
  • 资助金额:
    $ 1.7万
  • 项目类别:
Lipid Core
脂质核心
  • 批准号:
    6946093
  • 财政年份:
    2005
  • 资助金额:
    $ 1.7万
  • 项目类别:
LDL Cholesteryl Ester Metabolism in Atherosclerosis
动脉粥样硬化中的 LDL 胆固醇酯代谢
  • 批准号:
    7000684
  • 财政年份:
    2004
  • 资助金额:
    $ 1.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了